Growth Metrics

Armata Pharmaceuticals (ARMP) Accounts Payables (2016 - 2018)

Armata Pharmaceuticals (ARMP) has disclosed Accounts Payables for 6 consecutive years, with $714000.0 as the latest value for Q3 2018.

  • Quarterly Accounts Payables fell 24.76% to $714000.0 in Q3 2018 from the year-ago period, while the trailing twelve-month figure was $714000.0 through Sep 2018, down 24.76% year-over-year, with the annual reading at $302000.0 for FY2017, 88.96% down from the prior year.
  • Accounts Payables hit $714000.0 in Q3 2018 for Armata Pharmaceuticals, up from $682000.0 in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $2.7 million in Q4 2016 to a low of $302000.0 in Q4 2017.
  • Historically, Accounts Payables has averaged $1.4 million across 5 years, with a median of $1.2 million in 2014.
  • Biggest five-year swings in Accounts Payables: skyrocketed 161.97% in 2016 and later crashed 88.96% in 2017.
  • Year by year, Accounts Payables stood at $1.2 million in 2014, then dropped by 10.54% to $1.0 million in 2015, then soared by 161.97% to $2.7 million in 2016, then plummeted by 88.96% to $302000.0 in 2017, then surged by 136.42% to $714000.0 in 2018.
  • Business Quant data shows Accounts Payables for ARMP at $714000.0 in Q3 2018, $682000.0 in Q2 2018, and $810000.0 in Q1 2018.